Protara Therapeutics, Inc. (TARA) SEC filings
TARA SEC filings moved a median of -1.41% by the close. TARA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TARA overview →
61 measured TARA SEC filing events.
Where these TARA SEC filings landedvs 60 measured TARA SEC filing reactions
| Middle 50% of TARA SEC filing reactions | -2.73% to +2.33% |
|---|---|
| Median reaction (to close) | -1.41% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 TARA SEC filing events with a measured close landed between -2.73% and +2.33%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Protara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.25% | -2.25% | |
| Form 8-K Protara Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -1.25% | -2.25% | |
| Form S-8 Protara Therapeutics, | SEC filing · Form S-8 | -0.25% | -2.75% | |
| Form 8-K Protara Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -3.99% | -4.74% | |
| Form 8-K Protara Therapeutics, For: Jun 12 | SEC filing · Form 8-K | -1.77% | -3.54% | |
| Form EFFECT Protara Therapeutics, | SEC filing · Form EFFECT | -0.80% | -4.00% | |
| Form S-3 Protara Therapeutics, | SEC filing · Form S-3 | -0.10% | +1.73% | |
| Form 10-Q Protara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.77% | -1.89% | |
| Form 8-K Protara Therapeutics, For: May 13 | SEC filing · Form 8-K | -3.77% | -1.89% | |
| Form ARS Protara Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.99% | +2.17% | |
| Form DEF 14A Protara Therapeutics, For: Jun 12 | SEC filing · Form DEF | +0.99% | +2.17% | |
| Form DEFA14A Protara Therapeutics, | SEC filing · Form DEFA14A | +0.99% | +2.17% | |
| Form PRE 14A Protara Therapeutics, For: Apr 17 | SEC filing · Form PRE | -0.37% | -1.67% | |
| Form 8-K Protara Therapeutics, For: Mar 30 | SEC filing · Form 8-K | +0.00% | -1.62% | |
| Form 10-K Protara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.73% | |
| Form 8-K Protara Therapeutics, For: Mar 10 | SEC filing · Form 8-K | +0.00% | -2.73% | |
| Form 8-K Protara Therapeutics, For: Feb 23 | SEC filing · Form 8-K | -2.24% | -12.48% | |
| Form 8-K Protara Therapeutics, For: Dec 15 | SEC filing · Form 8-K | +1.09% | -1.27% | |
| Form 8-K Protara Therapeutics, For: Dec 04 | SEC filing · Form 8-K | -0.49% | +1.24% | |
| Form 8-K Protara Therapeutics, For: Dec 03 | SEC filing · Form 8-K | -0.89% | +1.19% | |
| Form 8-K Protara Therapeutics, For: Nov 19 | SEC filing · Form 8-K | -5.88% | +5.17% | |
| Form 10-Q Protara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.82% | +5.84% | |
| Form 8-K Protara Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +0.82% | +5.84% | |
| Form 10-Q Protara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.28% | -0.96% | |
| Form 8-K Protara Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -1.28% | -0.96% | |
| Form S-8 Protara Therapeutics, | SEC filing · Form S-8 | -3.56% | — | |
| Form 8-K Protara Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +0.31% | -2.48% | |
| Form 10-Q Protara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.02% | -1.46% | |
| Form 8-K Protara Therapeutics, For: May 08 | SEC filing · Form 8-K | +1.02% | -1.46% | |
| Form 8-K Protara Therapeutics, For: Apr 26 | SEC filing · Form 8-K | -20.60% | -13.94% | |
| Form ARS Protara Therapeutics, For: Dec 31 | SEC filing · Form ARS | -20.60% | -13.94% | |
| Form DEF 14A Protara Therapeutics, For: Jun 11 | SEC filing · Form DEF | -20.60% | -13.94% | |
| Form DEFA14A Protara Therapeutics, | SEC filing · Form DEFA14A | -20.60% | -13.94% | |
| Form 10-K Protara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.08% | +8.04% | |
| Form 8-K Protara Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +2.08% | +8.04% | |
| Form S-8 Protara Therapeutics, | SEC filing · Form S-8 | -0.27% | +7.40% | |
| Form 8-K Protara Therapeutics, For: Jan 13 | SEC filing · Form 8-K | +0.57% | -4.92% | |
| Form 8-K Protara Therapeutics, For: Dec 09 | SEC filing · Form 8-K | -1.56% | -1.11% | |
| Form 8-K Protara Therapeutics, For: Dec 05 | SEC filing · Form 8-K | +1.48% | -36.30% | |
| Form 10-Q Protara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.79% | |
| Form 8-K Protara Therapeutics, For: Nov 12 | SEC filing · Form 8-K | — | +1.98% | |
| Form 10-Q Protara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.36% | |
| Form 8-K Protara Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.00% | -2.36% | |
| Form S-8 Protara Therapeutics, | SEC filing · Form S-8 | +0.00% | -12.04% | |
| Form 8-K Protara Therapeutics, For: Jun 07 | SEC filing · Form 8-K | -1.32% | +3.01% | |
| Form EFFECT Protara Therapeutics, | SEC filing · Form EFFECT | +0.31% | -5.96% | |
| Form 10-Q Protara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.17% | -2.37% | |
| Form 8-K Protara Therapeutics, For: May 02 | SEC filing · Form 8-K | -0.17% | -2.37% | |
| Form S-3 Protara Therapeutics, | SEC filing · Form S-3 | +1.72% | +0.00% | |
| Form ARS Protara Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.17% | +6.16% | |
| Form DEF 14A Protara Therapeutics, For: Jun 07 | SEC filing · Form DEF | +0.17% | +6.16% | |
| Form DEFA14A Protara Therapeutics, | SEC filing · Form DEFA14A | +0.17% | +6.16% | |
| Form 8-K Protara Therapeutics, For: Apr 05 | SEC filing · Form 8-K | +2.55% | -22.77% | |
| Form 8-K Protara Therapeutics, For: Mar 18 | SEC filing · Form 8-K | +0.00% | +1.27% | |
| Form S-8 Protara Therapeutics, | SEC filing · Form S-8 | +0.00% | +4.54% | |
| Form 10-K Protara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.43% | -1.35% | |
| Form 8-K Protara Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -2.43% | -1.35% | |
| Form EFFECT Protara Therapeutics, | SEC filing · Form EFFECT | +0.00% | -3.23% | |
| Form 10-Q Protara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.90% | +8.87% | |
| Form 8-K Protara Therapeutics, For: Nov 03 | SEC filing · Form 8-K | +2.90% | +8.87% | |
| Form S-3 Protara Therapeutics, | SEC filing · Form S-3 | +2.90% | +8.87% |
Keep exploring
More TARA: earnings → · analyst actions → · TARA overview →